RELAPSED OR REFRACTORY SOLID TUMORS Clinical Trials

15 clinical trials for RELAPSED OR REFRACTORY SOLID TUMORS across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A PHASE I STUDY OF GCAR1, A CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR PARTICIPANTS WITH SELECTED RELAPSED/REFRACTORY GPNMB-EXPRESSING SOLID TUMOURS — RECRUITING · PHASE1
• PHASE I/II STUDY OF SILMITASERTIB (CX-4945) IN COMBINATION WITH CHEMOTHERAPY IN CHILDREN AND YOUNG ADULTS WITH RELAPSED REFRACTORY SOLID TUMORS — RECRUITING · PHASE1
• A PHASE I-II, FIRST-IN-HUMAN STUDY OF SKB264 IN PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE /METASTATIC SOLID TUMORS WHO ARE REFRACTORY TO AVAILABLE STANDARD THERAPIES. — RECRUITING · PHASE1
• A PHASE 1/ 2 STUDY OF BAY 1895344 (ELIMUSERTIB, IND#152153, NSC#810486) IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS — RECRUITING · PHASE1
• A PHASE I/II STUDY OF NERATINIB IN PEDIATRIC PATIENTS WITH RELAPSED/ REFRACTORY SOLID TUMORS — RECRUITING · PHASE1
• A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) — COMPLETED · PHASE2
• A PHASE 1/2 TRIAL OF CBL0137 (NSC# 825802, IND# 155843) IN PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS INCLUDING CNS TUMORS AND LYMPHOMA — NOT_YET_RECRUITING · PHASE1
• Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer — TERMINATED · PHASE1
• A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors — COMPLETED · PHASE1
• PHASE 1 STUDY OF THE BROMODOMAIN (BRD) AND EXTRA-TERMINAL DOMAIN (BET) INHIBITOR BMS-986158 IN PEDIATRIC CANCER — COMPLETED · PHASE1
• A PHASE I, MULTICENTER DOSE-ESCALATION STUDY TO ASSESS THE TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ANTI-TUMOR ACTIVITY OF AZD5153 IN PATIENTS WITH RELAPSED/REFRACTORY MALIGNANT SOLID TUMORS, INCLUDING LYMPHOMAS — COMPLETED · PHASE1
• A PHASE 1 FIRST-IN-HUMAN STUDY WITH ABBV-155 ALONE AND IN COMBINATION WITH TAXANE THERAPY IN ADULTS WITH RELAPSED AND/OR REFRACTORY SOLID TUMORS — COMPLETED · PHASE1
• A PHASE 1/IIA STUDY OF DECITABINE IN COMBINATION WITH GENISTEIN IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS AND LEUKEMIA — COMPLETED · PHASE1
• A PHASE 1 STUDY OF THE VEGF RECEPTOR TYROSINE KINASE INHIBITOR AXITINIB (INLYTA, IND# 123101) IN CHILDREN WITH RECURRENT OR REFRACTORY SOLID TUMORS — NOT_YET_RECRUITING · PHASE1
• A PHASE 1/2 STUDY OF MK-1775 (AZD1775, IND# 121422) IN COMBINATION WITH ORAL — COMPLETED · PHASE1

Refine this search